Cardlytics (CDLX) raises Q1 revenue guidance as buying pressure mounts

The stock of finance-focused digital advertising platform Cardlytics (NASDAQ: CDLX), which had been on the downside for most of the past month, has suddenly experienced a significant uptick upon the company announcing its updated guidance for the first quarter of 2023.

Indeed, the updated guidance on Cardlytics’ financial results for the quarter ending March 31, 2023, shows higher billings, revenue, and adjusted contribution, than on previously reported guidance, according to the company’s press release on April 4.

*Cardlytics previously reported vs. updated guidance for Q1 2023. Source:* *GlobeNewswire*

Commenting on the update, Cardlytics CEO Karim Temsamani said:

“Our improved topline guidance is driven by better-than-expected growth in the U.S. business and the product optimizations discussed on our last earnings call. (…) We are confidently navigating 2023 and look forward to sharing more positive updates over the coming months.”

Cardlytics stock responds

Shortly after the announcement, the Cardlytics stock witnessed “an abrupt price boost on high relative volume (11 RVOL),” as earlier observed on the Twitter page of the stock market analytics and monitoring platform TT Day Trading Alerts.

*Cardlytics price and volume on April 4. Source:* *TT Day Trading Alerts*

As things stand, CDLX is currently changing hands at $4.64, up more than 30% in the last 24 hours and nearly 64% in the past five days, as per the latest Google Finance real-time market data obtained by Finbold on April 4.

*Cardlytics five-day price chart. Source:* *Google Finance*

With the newest results, the CDLX stock has broken through the previous resistance level at $4.24, set by the stock trader and finance analyst Tiger Line Trading, and is now on the way towards the New High of Day (NHOD), as the expert projected earlier during the day.

*Cardlytics price candles on April 4. Source:* *Tiger Line Trading*

Interestingly, investment analyst Austin Swanson stated earlier in March that CDLX could increase its price in April based on factors such as possible upcoming announcements on better earnings results, as well as the updated liquidity analysis, among other things.

Buy stocks now with Interactive Brokers – the most advanced investment platform

Disclaimer: The content on this site should not be considered investment advice. Investing is speculative. When investing, your capital is at risk.

Source: https://finbold.com/stock-to-watch-cardlytics-cdlx-raises-q1-revenue-guidance-as-buying-pressure-mounts/